Opening Soon
Source verified July 9, 2026
Kanta Marwah Research Innovation Fund
Flexible funding for Parkinson’s research innovation
Offered by
Latest source updateLast Update: July 9, 2026Latest change: Parkinson Canada updated its 2026 research competition with new dates, a new GBA1 Parkinson’s Disease Research Catalyst Program, revised award values, and updated application guidance.View change
Latest source update
Last Update: July 9, 2026
Latest change: Parkinson Canada updated its 2026 research competition with new dates, a new GBA1 Parkinson’s Disease Research Catalyst Program, revised award values, and updated application guidance.
2026 Parkinson research competition update
The 2026 research competition now lists an application phase opening August 4, 2026, an informational webinar on August 12, 2026 at 12 p.m. ET, advisory group meetings on August 24, 2026 and September 15, 2026, a deadline of October 5, 2026 at 5 p.m. ET, a review period of October 2026 to February 2027, and funding notifications in March 2027. The page also says updated RFAs will be posted in July 2026 and introduces a new GBA1 Parkinson’s Disease Research Catalyst Program with full proposals due July 22, 2026 at 5 p.m. ET. Updated award values are now shown for the Graduate Student Award from $20,000 per year to $40,000 per year for a 2-year term, the Postdoctoral Research Fellowship from $45,000 per year to $70,000 per year for a 2-year term, and the Pilot Project Grant from $75,000 over 1 year to $100,000 per year for up to 2 years.
Funding available
Varies by project
Deadline
October 5, 2026
Opened August 4, 2026
Location
Quebec, Canada
Overview
The Kanta Marwah Research Innovation Fund supports researchers, non-profit organizations, and private organizations focused on Parkinson's in Canada. It funds collaborative meetings, expansion of existing studies, and translational research that help address unmet needs and move discoveries toward the clinic.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop strategic partnerships
- Conduct research and development activities
Eligible Funding
- Varies by project
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Quebec
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Research
Target groups
- All the groups
Revenue structures
- 100% donations / grants
- Mixed revenue (<50% earned)
Scope
- Local
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Collaborative forums for knowledge exchange and consensus-building activities.
- Expansion of existing research projects by adding a new Parkinson's study arm or a Canadian site or collaborator.
- Preclinical or clinical development of translational research projects to bring novel therapies or diagnostic technologies to the clinic.
Documents Needed
- 1-page letter of intent.
- Biographical sketch (4 pages max each) for the applicant and all named key personnel.
- Project narrative (short application: 2 pages max; full application: 5 pages max including references).
- Budget.
- Supplementary materials, including previous publications or white papers (max 3) and letters of support from collaborators (max 1 page each).
Official resources
Eligibility
Who is eligible?
- Researchers with a focus on Parkinson's.
- Non-profit organizations with a focus on Parkinson's.
- Private organizations with a focus on Parkinson's.
Eligible expenses
- Costs associated with hosting meetings.
- Travel and accommodation for participants.
- Operating expenses for expanding research studies.
Selection criteria
- Appropriate fit for funding from the KMRIF.
- Alignment with Parkinson Canada's funding priorities.
- Availability of funds.
How to apply
- Submit a 1-page letter of intent to Parkinson Canada at research@parkinson.ca.
- Include the background of your initiative, the rationale for KMRIF funding, the current funding status of the project, the desired outcome or research question, the main aims or milestones, the budget, and the timeline for completion.
- You may schedule a meeting with Parkinson Canada Research before submitting the letter of intent.
- For meetings, consortia or strategic partnership initiatives, submit a description of the initiative purpose, key stakeholders and event, plus a budget; for research projects, clinical trials or transformational research studies, submit a biographical sketch, project narrative, budget, and supplementary materials.
Processing and Agreement
- LOIs are reviewed internally by Parkinson Canada in consultation with the chairs of the Research and Clinical Advisory Committee and the Scientific Advisory Council to evaluate fit for KMRIF funding and decide the review path.
- Funding requests of $20,000 or less for meetings, consortia or strategic partnership initiatives can be reviewed by the Parkinson Canada Research Team and may not require peer review.
- Projects that have already undergone peer review by a recognized research funding agency and have successfully received grant funding may be eligible for KMRIF funds without a formal peer review process.
- If a project has no new aims, a short application may be requested; if new aims are proposed or formal review is required, Parkinson Canada may request a full application and expert external reviewers may be recruited to assess it.
- Final approval and notice of funding are contingent on Board approval.
Additional information
- Applicants may contact Parkinson Canada Research to discuss project fit before submitting a letter of intent.
- Proposals are reviewed case by case based on alignment with Parkinson Canada priorities.
- Independent peer review may be required for some projects.
- Final funding approval is subject to Board approval.
Contacts
Frequently Asked Questions about the Kanta Marwah Research Innovation Fund Program
What is the Kanta Marwah Research Innovation Fund?
The Kanta Marwah Research Innovation Fund supports researchers, non-profit organizations, and private organizations focused on Parkinson's in Canada. It funds collaborative meetings, expansion of existing studies, and translational research that help address unmet needs and move discoveries toward the clinic.
What is the deadline to apply?
Applications will open on August 4, 2026.
Who is eligible for the Kanta Marwah Research Innovation Fund program?
To be eligible for the Kanta Marwah Research Innovation Fund program, you must:
The project must focus on Parkinson's and address an unmet need.
The proposal must fit a KMRIF funding stream.
Translational biotechnology or pharmaceutical projects must partner with a recognized Canadian research institution.
What expenses are eligible under Kanta Marwah Research Innovation Fund?
Collaborative forums for knowledge exchange and consensus-building activities.
Expansion of existing research projects by adding a new Parkinson's study arm or a Canadian site or collaborator.
Preclinical or clinical development of translational research projects to bring novel therapies or diagnostic technologies to the clinic.
Who can I contact for more information about the Kanta Marwah Research Innovation Fund?
You can contact Parkinson Canada Inc. by email at research@parkinson.ca or by phone at 1-800-565-3000.
Where is the Kanta Marwah Research Innovation Fund available?
The Kanta Marwah Research Innovation Fund program is available the province of Quebec.
Is the Kanta Marwah Research Innovation Fund a grant, loan, or tax credit?
Kanta Marwah Research Innovation Fund is a Grant and Funding